openPR Logo
Press release

Age-Related Macular Degeneration Therapeutics - Pipeline Analysis, Clinical Trials and Developments

10-18-2018 12:04 PM CET | Health & Medicine

Press release from: P&S Intelligence - Healthcare

Age-Related Macular Degeneration Therapeutics - Pipeline

As per the findings of the research, most of the drug candidates of Age-related macular degeneration pipeline are being developed to be administered by intra-vitreal route.

Explore report sample at: https://www.psmarketresearch.com/market-analysis/age-related-macular-degeneration-therapeutics-pipeline-analysis/report-sample

Many technologies are being developed that can bring the innovative treatment which can control the progression of Age-related macular degeneration. Some of these technologies include but are not limited to, HINGESCREEN technology platform, and CrossMab technology platform.

There are different novel molecule types that are present in the therapeutic pipeline of Age-related macular degeneration. Opregen is being developed by Cell Cure Neurosciences. Opregen is a stem cells molecule type useful in the treatment of Age-related macular degeneration.

Browse report at: https://www.psmarketresearch.com/market-analysis/age-related-macular-degeneration-therapeutics-pipeline-analysis

Some of the key players developing drugs for Age-related macular degeneration include Formycon, AG, Allergan Plc, Hoffmann-La Roche, and others.

About P&S Intelligence

P&S Intelligence, a brand of P&S Market Research, is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Age-Related Macular Degeneration Therapeutics - Pipeline Analysis, Clinical Trials and Developments here

News-ID: 1312735 • Views:

More Releases from P&S Intelligence - Healthcare

Cleanroom Technology Market Report 2023 by Key Players Analysis - Kimberly-Clark, Azbil Corporation, Ardmac, Alpiq, Illinois Tool Works Inc
Cleanroom Technology Market Report 2023 by Key Players Analysis - Kimberly-Clark …
According to a recent research report by P&S Intelligence, the global cleanroom technology size is projected to reach $5.0 billion by 2023. Various factors leading to the growth of the global cleanroom technology market include increasing demand for certified products, technological advancements in cleanrooms, growing prevalence of infectious diseases etc. **Download report sample at: http://bit.ly/2x2XXka With the increased number of biological products coming to the market, new practices to provide high assurance
Increasing Prevalence of Skin Problems is Driving the Growth of the Middle Eastern Market
Increasing Prevalence of Skin Problems is Driving the Growth of the Middle Easte …
According to P&S Intelligence, Middle East dermal fillers market is projected to cross $67.7 million by 2023, growing at a CAGR of 11.9% between 2018-2023. The growth is mainly led by increasing prevalence of skin problems, growing aging population, increasing awareness about age related skin problems, thriving medical tourism industry, and increase in disposable income. Explore report sample at: https://www.psmarketresearch.com/market-analysis/middle-east-dermal-fillers-market/report-sample Injectable lip enhancement is a procedure of strategically injecting dermal fillers into
Molecular Biology Kits and Reagents and Enzymes Market Trends, Share, Growth Drivers and Forecast to 2022
Molecular Biology Kits and Reagents and Enzymes Market Trends, Share, Growth Dri …
The molecular biology kits and reagents and enzymes market is growing due to increasing geriatric population, increasing prevalence of infectious diseases, and growing cases with genetic disorders. In addition, increasing healthcare expenditure resulting in improvement in research activities is further driving the market growth. Explore report sample at: https://www.psmarketresearch.com/market-analysis/molecular-biology-kits-and-reagents-and-enzymes-market/report-sample Based on product, kits and reagents accounted for the largest market in the global market in 2015, and it is expected to witness
Adhesion Barrier Market Overview, Applications, Growth Drivers, Insights and Status 2023
Adhesion Barrier Market Overview, Applications, Growth Drivers, Insights and Sta …
Global adhesion barrier market is forecasted to generate revenue of $833.1 million by 2023. The market is mainly driven by rise in technological advancements, growing geriatric population, and rising number of surgical procedures. Download report sample at: https://www.psmarketresearch.com/market-analysis/adhesion-barrier-market/report-sample The different types of products available in the adhesion barrier market are synthetic and natural adhesion prevention products. Synthetic category is expected to observe faster growth in demand, witnessing a CAGR of 7.9% during

All 5 Releases


More Releases for Opregen

Geographic Atrophy Treatment Market is expected to grow steeply with a CAGR of ~ …
(Albany, US) DelveInsight's Geographic Atrophy Market Analysis Report proffers a comprehensive outlay of the Geographic Atrophy Epidemiological analysis focusing on the incidence and diagnosed patient pool segmented on the basis of several factors, as well as the Geographic Atrophy market analysis in the 7MM (the US, EU5 (the UK, France, Germany, Italy and Spain) and Japan). The report covers the Geographic Atrophy market trends covering key pharmaceutical companies in the market,
Dry Age-related Macular Degeneration Pipeline and Clinical Trials Analysis by De …
Dry Age-related Macular Degeneration constitutes 45+ key companies continuously working towards developing 45+ Dry Age-related Macular Degeneration treatment therapies, analyzes DelveInsight. DelveInsight's 'Dry Age-related Macular Degeneration Pipeline Insight 2022' report provides comprehensive global coverage of available, marketed, and pipeline Dry AMD therapies in various stages of clinical development, major pharmaceutical players working to advance the pipeline space and future growth potential of the Dry Age-related Macular Degeneration pipeline domain. Find a sample
Age-Related Macular Degeneration Therapeutics Analysis - Formycon AG, Allergan, …
As per the findings of the research, most of the drug candidates of Age-related macular degeneration pipeline are being developed to be administered by intra-vitreal route. Download free report sample at: https://www.psmarketresearch.com/market-analysis/age-related-macular-degeneration-therapeutics-pipeline-analysis/report-sample *New innovating technologies offer development of promising drugs Many technologies are being developed that can bring the innovative treatment which can control the progression of Age-related macular degeneration. Some of these technologies include but are not limited to, HINGESCREEN technology platform,
BioTime Inc (BTX) - Product Pipeline Analysis, 2017 Update
Report Hive Market Research Released a New Research Report of 57 pages on Title " BioTime Inc (BTX) - Product Pipeline Analysis, 2017 Update "with detailed Analysis, Forecast and Strategies. Summary BioTime Inc (BioTime) is a biotechnology company which focuses on regenerative medicine and plasma volume expanders. The company’s Hextend is a blood plasma volume expander used for the treatment of hypovolemia in surgery, emergency trauma treatment, and other applications. The company
Age-related Macular Degeneration Exhibits Emerging Pipeline with 55 Drug Candida …
The study analysed that the Age-related related macular degeneration therapeutics pipeline comprises of approximately 55 drug candidates, of which five drug candidates are in the Phase III stage, 12 drug candidates are in Phase II stage, 11 drug candidates are in Phase I, 24 drug candidates are in Pre-clinical stage, and there are three drug candidates which are in Discovery stage. Age-related macular degeneration is a disorder that causes loss